Login / Signup

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity-modulated radiotherapy era.

Shan-Shan YangYa-Jun PangZhi-Qiang WangBao-Yu ZhangZhi-Qiao LiuEn-Ni ChenPu-Yun OuYangFang-Yun Xie
Published in: Cancer medicine (2021)
A risk score model was developed and prospectively validated to precisely select high-risk stage II NPC patients who can benefit from CCRT, and thus guided individualized treatment in IMRT era.
Keyphrases
  • locally advanced
  • rectal cancer
  • early stage
  • radiation therapy
  • squamous cell carcinoma
  • radiation induced
  • replacement therapy